These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26959706)

  • 41. Genetic aspects of stroke: human and experimental studies.
    Carr FJ; McBride MW; Carswell HV; Graham D; Strahorn P; Clark JS; Charchar FJ; Dominiczak AF
    J Cereb Blood Flow Metab; 2002 Jul; 22(7):767-73. PubMed ID: 12142561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene-environment interaction in hypertension, stroke and atherosclerosis in experimental models and supportive findings from a world-wide cross-sectional epidemiological survey: a WHO-cardiac study.
    Yamori Y; Nara Y; Mizushima S; Murakami S; Ikeda K; Sawamura M; Nabika T; Horie R
    Clin Exp Pharmacol Physiol Suppl; 1992; 20():43-52. PubMed ID: 1446409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The contribution of host genetics to tuberculosis pathogenesis.
    Schurr E
    Kekkaku; 2011 Jan; 86(1):17-28. PubMed ID: 21401002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic basis of stroke: an overview.
    Munshi A; Kaul S
    Neurol India; 2010; 58(2):185-90. PubMed ID: 20508333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relative importance of common and rare genetic variants in the development of hypertriglyceridemia.
    Evans D; Aberle J; Beil FU
    Expert Rev Cardiovasc Ther; 2011 May; 9(5):637-44. PubMed ID: 21615327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Temporal trends in the incidence and recurrence of hospitalised atherothrombotic disease in an Australian population, 2000-07: data linkage study.
    Nedkoff L; Briffa TG; Knuiman M; Hung J; Norman PE; Hankey GJ; Thompson PL; Geelhoed E; Sanfilippo FM; Hickling S; Bremner A; Hobbs M
    Heart; 2012 Oct; 98(19):1449-56. PubMed ID: 22821274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combining genome-wide data from humans and animal models of dyslipidemia and atherosclerosis.
    Berisha SZ; Smith JD
    Curr Opin Lipidol; 2011 Apr; 22(2):100-5. PubMed ID: 21178769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The genetics of panic disorder.
    Schumacher J; Kristensen AS; Wendland JR; Nöthen MM; Mors O; McMahon FJ
    J Med Genet; 2011 Jun; 48(6):361-8. PubMed ID: 21493958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
    Auxéméry Y
    Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular genetics of Alzheimer's disease and aging.
    Cacabelos R; Fernandez-Novoa L; Lombardi V; Kubota Y; Takeda M
    Methods Find Exp Clin Pharmacol; 2005 Jul; 27 Suppl A():1-573. PubMed ID: 16470248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of common unfavourable genetic variants in cerebrovascular diseases: recommendation for supportive genetic examinations and methodological approaches for common genetic variants.
    Szolnoki Z
    Curr Med Chem; 2009; 16(24):3168-73. PubMed ID: 19689290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PCSK9 gene mutations and low-density lipoprotein cholesterol.
    Wu NQ; Li JJ
    Clin Chim Acta; 2014 Apr; 431():148-53. PubMed ID: 24518357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic basis of susceptibility to teratogen induced birth defects.
    Wlodarczyk BJ; Palacios AM; Chapa CJ; Zhu H; George TM; Finnell RH
    Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):215-26. PubMed ID: 21766441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic stabilization of transthyretin, cerebrovascular disease, and life expectancy.
    Hornstrup LS; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1441-7. PubMed ID: 23580146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The extended abnormalities in lipoprotein metabolism in familial hypercholesterolemia: developing a new framework for future therapies.
    Ooi EM; Barrett PH; Watts GF
    Int J Cardiol; 2013 Oct; 168(3):1811-8. PubMed ID: 23907036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging PCSK9 inhibitors for treating dyslipidaemia: buttressing the gaps in coronary prevention.
    Page MM; Watts GF
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):299-312. PubMed ID: 25861882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetics of anxiety disorders: Genetic epidemiological and molecular studies in humans.
    Shimada-Sugimoto M; Otowa T; Hettema JM
    Psychiatry Clin Neurosci; 2015 Jul; 69(7):388-401. PubMed ID: 25762210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel biological insights emerging from genetic studies of type 2 diabetes and related metabolic traits.
    De Silva NM; Frayling TM
    Curr Opin Lipidol; 2010 Feb; 21(1):44-50. PubMed ID: 19956073
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease.
    Abifadel M; Rabès JP; Devillers M; Munnich A; Erlich D; Junien C; Varret M; Boileau C
    Hum Mutat; 2009 Apr; 30(4):520-9. PubMed ID: 19191301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.